Company Information
USD
770
- (-0.1%)
NYSE:LLY, ELI LILLY AND COMPANY
Industry: Drug Manufacturers - General
End of Day: 17 May 2024 GMT-4
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Address
Lilly Corporate Center
Website
Classification
Sector
Healthcare
Industry Group
Drug Manufacturers
Industry
Drug Manufacturers - General
Key Executives
Ms. Gabrielle Sulzberger
Director
Mr. Jon Erik Fyrwald
Director
Mr. Juan R. Luciano
Director
Dr. Mary Lynne Hedley,PhD
Director
Mr. Ralph Alvarez
Director
Ms. Katherine Baicker
Director
Mr. David A. Ricks
CEO/Chairman of the Board/Director/President
Dr. William G. Kaelin, Jr
Director
Mr. Donald A. Zakrowski
Chief Accounting Officer/Senior VP, Divisional
Mr. Marschall S. Runge
Director
Mr. Jamere Jackson
Director
Mr. Jacob S. Van Naarden
Executive VP/President, Subsidiary
Ms. Kimberly H. Johnson
Director
Ms. Karen Walker
Director
Ms. Anat Hakim
Executive VP/General Counsel/Secretary
Ms. Johna L. Norton
Executive VP, Divisional
Dr. Daniel M. Skovronsky, M.D.
Chief Scientific Officer/Executive VP/President, Divisional
Ms. Anne E. White
Executive VP/President, Divisional
Mr. Patrik Jonsson
Executive VP, Divisional/President, Divisional/President, Geographical
Mr. Ilya Yuffa
Executive VP/President, Subsidiary
Ms. Anat Ashkenazi
CFO/Executive VP
Mr. Edgardo Hernandez
Executive VP/President, Divisional
Mr. Diogo Rau
Chief Information Officer/Executive VP/Other Executive Officer
Mr. Alonzo Weems
Chief Compliance Officer/Executive VP, Divisional/Other Executive Officer
Mr. Eric Dozier
Executive VP, Divisional
Ownership
Institution Holdings
Lilly Endowment Inc
99,768,810 (10.500%)
Vanguard Group Inc
71,611,201 (7.537%)
BlackRock Inc
64,366,433 (6.774%)
PNC Financial Services Group Inc
51,789,291 (5.451%)
Capital Research and Management Company
39,925,234 (4.202%)
Fidelity Management & Research Company LLC
34,178,563 (3.597%)
State Street Corporation
33,787,327 (3.556%)
FMR Inc
32,845,420 (3.457%)
Capital Group
27,965,997 (2.943%)
Vanguard Investments Australia Ltd
27,285,971 (2.872%)
Funds Holdings
Vanguard US Total Market Shares ETF
26,857,819 (2.827%)
Vanguard Total Stock Market Index Fund
26,857,819 (2.827%)
Vanguard Institutional 500 Index Trust
19,706,689 (2.074%)
Vanguard PrimeCap Fund
12,848,118 (1.352%)
Fidelity 500 Index Fund
9,467,553 (0.996%)
SPDR® S&P 500 ETF Trust
9,359,505 (0.985%)
iShares Core S&P 500 ETF
8,296,124 (0.873%)
Vanguard Growth Index Fund
7,872,938 (0.829%)
American Funds Growth Fund of Amer
7,349,331 (0.773%)
Capital Group Growth Fnd of Amer Comp
7,349,331 (0.773%)
Make Smart Investment Choices